Cargando…

First-in-man Implantation of the XINSORB Bioresorbable Sirolimus-eluting Scaffold in China

Detalles Bibliográficos
Autores principales:	Chen, Jia-Hui, Wu, Yi-Zhe, Shen, Li, Zhang, Feng, Yao, Zhi-Feng, Yin, Jia-Sheng, Ji, Meng, Wang, Qi-Bing, Ge, Lei, Qian, Ju-Ying, Hu, Xi, Xie, Jian, Ge, Jun-Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831559/ https://www.ncbi.nlm.nih.gov/pubmed/25947415 http://dx.doi.org/10.4103/0366-6999.156155

Ejemplares similares

Three-year clinical outcomes of a sirolimus-eluting bioresorbable scaffold (XINSORB) and a metallic stent to treat coronary artery stenosis
por: Wu, Yizhe, et al.
Publicado: (2020)

Final report of the 5-year clinical outcomes of the XINSORB bioresorbable sirolimus-eluting scaffold in the treatment of single de novo coronary lesions in a first-in-human study
por: Wu, Yizhe, et al.
Publicado: (2020)

The standard versus prolonged dual antiplatelet therapy after the XINSORB bioresorbable scaffold implantation (SPARTA) trial: study protocol for a randomized controlled trial
por: Wu, Yizhe, et al.
Publicado: (2023)

Clinical and Angiographic Outcomes of the First Korean-made Sirolimus-Eluting Coronary Stent with Abluminal Bioresorbable Polymer
por: Yang, Hyoung-Mo, et al.
Publicado: (2017)

Coronary Endothelium‐Dependent Vasomotor Function After Drug‐Eluting Stent and Bioresorbable Scaffold Implantation
por: Gomez‐Lara, Josep, et al.
Publicado: (2021)

Electrospun Bioresorbable Membrane Eluting Chlorhexidine for Dental Implants
por: Pouponneau, Pierre, et al.
Publicado: (2020)

Early scaffold strut coverage in ultra-high molecular weight amorphous PLLA sirolimus-eluting bioresorbable scaffolds: impact of strut thickness assessed in normal porcine coronary arteries
por: Gąsior, Paweł, et al.
Publicado: (2020)

Mechanical properties of the everolimus-eluting bioresorbable vascular scaffold compared to the metallic everolimus-eluting stent
por: Dalos, Daniel, et al.
Publicado: (2016)

Mechanical properties of the drug‐eluting bioresorbable magnesium scaffold compared with polymeric scaffolds and a permanent metallic drug‐eluting stent
por: Barkholt, Trine Ø., et al.
Publicado: (2019)

Bioresorbable Drug-Eluting Magnesium-Alloy Scaffold for Treatment of Coronary Artery Disease
por: Campos, Carlos M., et al.
Publicado: (2013)

Comparison of Acute Recoil between Bioabsorbable Poly-L-lactic Acid XINSORB Stent and Metallic Stent in Porcine Model
por: Wu, Yizhe, et al.
Publicado: (2012)

Nine-month Angiographic and Two-year Clinical Follow-up of Novel Biodegradable-polymer Arsenic Trioxide-eluting Stent Versus Durable-polymer Sirolimus-eluting Stent For Coronary Artery Disease
por: Shen, Li, et al.
Publicado: (2015)

Pharmacokinetic Study of Sirolimus-Eluting BioResorbable Vascular Scaffold System for Treatment of De Novo Native Coronary Lesions: A Sub-Study of MeRes-1 Trial
por: Chandra, Praveen, et al.
Publicado: (2018)

Mechanical performance and healing patterns of the novel sirolimus-eluting bioresorbable Fantom scaffold: 6-month and 9-month follow-up by optical coherence tomography in the FANTOM II study
por: Simonsen, Jo Krogsgaard, et al.
Publicado: (2019)

Coronary Artery Vessel Healing Pattern, Short and Long Term, After Implantation of the Everolimus‐Eluting Bioresorbable Vascular Scaffold
por: Kraak, Robin P., et al.
Publicado: (2015)

Coronary Computed Tomography Angiography for the Assessment of Sirolimus-Eluting Resorbable Magnesium Scaffold
por: Tonet, Elisabetta, et al.
Publicado: (2022)

Chronic total occlusion successfully treated with a bioresorbable everolimus-eluting vascular scaffold
por: Rama-Merchan, Juan Carlos, et al.
Publicado: (2014)

The 2010s in clinical drug-eluting stent and bioresorbable scaffold research: a Dutch perspective
por: Kawashima, H., et al.
Publicado: (2020)

InSilc Computational Tool for In Silico Optimization of Drug-Eluting Bioresorbable Vascular Scaffolds
por: Milosevic, Miljan, et al.
Publicado: (2022)

Neointimal hyperplasia persists at six months after sirolimus-eluting stent implantation in diabetic porcine
por: Zhang, Qi, et al.
Publicado: (2007)

Safety and Efficacy of Everolimus-Eluting Bioresorbable Vascular Scaffold Versus Second-Generation Drug-Eluting Stents in Real-World Practice
por: Lee, Joo Myung, et al.
Publicado: (2023)

Comparison of everolimus-eluting and biolimus-eluting coronary stents with everolimus-eluting bioresorbable scaffold: study protocol of the randomized controlled EVERBIO II trial
por: Arroyo, Diego, et al.
Publicado: (2014)

Treatment of a Coronary Bifurcation Lesion Using One Dedicated Sirolimus Eluting Bifurcation Stent in Combination with a Bioresorbable Vascular Scaffold: A Novel Option for Coronary Bifurcation Approach
por: Benezet, Javier, et al.
Publicado: (2016)

Biodegradable Polymer DES (Ultimaster) vs. Magnesium Bioresorbable Scaffold (BRS Magmaris) in Diabetic Population with NSTE-ACS: A One-Year Clinical Outcome of Two Sirolimus-Eluting Stents
por: Rola, Piotr, et al.
Publicado: (2021)

Individual patient data analysis of the BIOFLOW study program comparing safety and efficacy of a bioresorbable polymer sirolimus eluting stent to a durable polymer everolimus eluting stent
por: Toelg, Ralph, et al.
Publicado: (2020)

Comparison of a Bioresorbable, Magnesium-Based Sirolimus-Eluting Stent with a Permanent, Everolimus-Eluting Metallic Stent for Treating Patients with Acute Coronary Syndrome: the PRAGUE-22 Study
por: Toušek, Petr, et al.
Publicado: (2021)

Everolimus-eluting bioresorbable vascular scaffold in daily clinical practice: A single-centre experience
por: Remkes, W. S., et al.
Publicado: (2017)

Conformability in everolimus-eluting bioresorbable scaffolds compared with metal platform coronary stents in long lesions
por: Fam, Jiang Ming, et al.
Publicado: (2017)

One-year efficacy and safety of everolimus-eluting bioresorbable scaffolds in the setting of acute myocardial infarction
por: Kim, Yongcheol, et al.
Publicado: (2020)

Randomized clinical trial comparing abluminal biodegradable polymer sirolimus-eluting stents with durable polymer sirolimus-eluting stents: Nine months angiographic and 5-year clinical outcomes
por: Zhang, Haijun, et al.
Publicado: (2016)

The endothelium permeability after bioresorbable scaffolds implantation caused by the heterogeneous expression of tight junction proteins
por: Huang, Junyang, et al.
Publicado: (2022)

Early-Period Coronary Aneurysm Formation After Sirolimus-Eluting Stent Implantation
por: Kaya, Cihad, et al.
Publicado: (2023)

Case series of coronary artery aneurysms after Everolimus eluting stent implantation and comparison with Sirolimus eluting stents
por: Sharma, Raghav, et al.
Publicado: (2022)

Bioresorbable Scaffolds: Contemporary Status and Future Directions
por: Peng, Xiang, et al.
Publicado: (2020)

Delayed neointimal healing pattern after bioresorbable scaffold implantation
por: Ochijewicz, D., et al.
Publicado: (2018)

Early experience and favorable clinical outcomes of everolimus-eluting bioresorbable scaffolds for coronary artery disease in Korea
por: Kwon, Osung, et al.
Publicado: (2018)

Long-term outcomes after treatment of in-stent restenosis using the Absorb everolimus-eluting bioresorbable scaffold
por: Madanchi, Mehdi, et al.
Publicado: (2021)

Long-term comparison of everolimus- vs. novolimus-eluting bioresorbable vascular scaffolds in real world patients
por: Cakal, Beytullah, et al.
Publicado: (2020)

Long-Term Performance of the Magmaris Drug-Eluting Bioresorbable Metallic Scaffold in All-Comers Patients’ Population
por: Al Nooryani, Arif, et al.
Publicado: (2022)

Sirolimus-eluting coronary stents: a review
por: Abizaid, Alexandre
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_bok39mvon6plfpr0errabg8avb